Jutta Fritz

Jutta Fritz has a diverse work experience in the biotechnology and healthcare industry. Jutta is currently the Founder and Chief Business Officer (CBO) at NEOsphere Biotechnologies GmbH, a position they have held since April 2022. Prior to this, they served as the Head of Business Development at HpH Institut für Hämatopathologie Hamburg from September 2019 to November 2021.

Jutta also founded and worked as the CBO at NEO New Oncology GmbH, which was later acquired by Siemens Healthineers in 2016. Jutta held this position from August 2012 to May 2019. Before that, they were the Vice President of Business Development at Evotec from February 2011 to August 2012.

Earlier in their career, Jutta served as the Head of Business Development at Kinaxo from January 2009 to February 2011. Jutta also gained experience as a Trainee in Patent & Licensing Management at Max-Planck-Innovation GmbH in 2008. Jutta started their professional journey as a Scientific Researcher at The University of Freiburg's Institute of Virology from 2003 to 2004.

Throughout their career, Jutta Fritz has demonstrated their expertise in business development and has played key roles in the growth and success of various biotechnology companies.

Jutta Fritz has an extensive education history. Jutta started their academic journey at The University of Freiburg from 1997 to 2002, where they obtained a Master of Science degree in Biology. Jutta'sfield of study during this period included Molecular Cell Biology, Genetics, Microbiology, and Virology. In 2003, Jutta enrolled in a correspondence degree course of study in Total Quality Management at RPTU Kaiserslautern-Landau, completing it in 2005.

Continuing their academic pursuits, Jutta pursued a Doctor of Philosophy degree in Molecular Biology at the University of Vienna. This phase of their education occurred from 2004 to 2007. Alongside their PhD, they also undertook an additional degree program in Financial Management at the University of Wales, Cardiff/Fernuniversität Hagen. This program lasted from 2005 to 2008, resulting in their earning a Master of Business Administration (MBA) degree.

Based on the provided information, Jutta's education journey showcases their dedication to both the life sciences, specifically Molecular Biology, and their interest in financial management.